Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Blood Advances
|
October 6, 2021
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting
Maria A V Marzolini, Varun Mehra, Kirsty J Thomson, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Transplantation and Cellular Therapy
|
July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Annalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
British Journal of Haematology
|
February 15, 2022
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Dawn Swan, Patrick J Hayden, Dirk-Jan Eikema, et al.
Haematologica
|
April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation
|
November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Kavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Blood
|
April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling
Giuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Blood Advances
|
October 6, 2021
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting
Maria A V Marzolini, Varun Mehra, Kirsty J Thomson, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Transplantation and Cellular Therapy
|
July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Annalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
British Journal of Haematology
|
February 15, 2022
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Dawn Swan, Patrick J Hayden, Dirk-Jan Eikema, et al.
Haematologica
|
April 23, 2026
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Laurien G A Baaij, et al.
Bone Marrow Transplantation
|
November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Kavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Blood
|
April 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling
Giuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Page
of 12